Diseases /

Myelodysplastic Syndrome with Isolated del(5q)

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: A myelodysplastic syndrome characterized by a deletion between bands q31 and 33 on chromosome 5. The number of blasts in the bone marrow and blood is <5%. The bone marrow is usually hypercellular or normocellular with increased number of often hypolobated megakaryocytes. The peripheral blood shows macrocytic anemia. This syndrome occurs predominantly but not exclusively in middle age to older women. The prognosis is good and transformation to acute leukemia is rare. (WHO, 2001) [1]

Clinical Trials

View Clinical Trials for Myelodysplastic Syndrome with Isolated del(5q)

Disease Details

Synonyms
Myelodysplastic Syndrome Associated with Isolated del (5q) Chromosome Abnormality, 5q- Syndrome, MDS with Isolated Del(5q), 5Q minus syndrome, 5Q- syndrome, Myelodysplastic Syndrome with 5q Deletion
Parent(s)
Myelodysplastic Syndromes
OncoTree Name
MDS with Isolated Del(5q)
OncoTree Code
MDSID5Q

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.